BRKB

482.17

+0.48%↑

BRKA.US

723,231.1

+0.48%↑

JPM

293.31

+0.92%↑

304.73

-0.37%↓

500.46

-0.64%↓

BRKB

482.17

+0.48%↑

BRKA.US

723,231.1

+0.48%↑

JPM

293.31

+0.92%↑

304.73

-0.37%↓

500.46

-0.64%↓

BRKB

482.17

+0.48%↑

BRKA.US

723,231.1

+0.48%↑

JPM

293.31

+0.92%↑

304.73

-0.37%↓

500.46

-0.64%↓

BRKB

482.17

+0.48%↑

BRKA.US

723,231.1

+0.48%↑

JPM

293.31

+0.92%↑

304.73

-0.37%↓

500.46

-0.64%↓

BRKB

482.17

+0.48%↑

BRKA.US

723,231.1

+0.48%↑

JPM

293.31

+0.92%↑

304.73

-0.37%↓

500.46

-0.64%↓

Начало・Списък с акции・Walker & Dunlop Inc

Walker & Dunlop Inc

Отворен

СекторФинансови

44.25 -0.74

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

43.52

Максимум

44.84

Ключови измерители
By Trading Economics
Приходи	-47M -14M
Продажби	2.3M 340M
P/E Средно за сектора	27.72 54.048
Дивидентна доходност	5.95
Марж на печалбата	-4.087
Служители	1,466
EBITDA	-46M 60M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+48.33% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	5.95% 4.84%
Следващи печалби	30.04.2026 г.
Следваща дата на дивидент	27.03.2026 г.
Следваща дата на екс-дивидент	14.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-539M 1.5B
Предишно отваряне	44.99
Предишно затваряне	44.25

Настроения в новините

By Acuity

50%

160 / 441 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

70.995 / 76.69 Подкрепа & съпротива

Walker & Dunlop Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.03.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23.03.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23.03.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23.03.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене

Значими събития в новините

Global Equities Roundup: Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене

Значими събития в новините

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23.03.2026 г., 22:40 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23.03.2026 г., 22:23 ч. UTC

Пазарно говорене

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23.03.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23.03.2026 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23.03.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23.03.2026 г., 22:08 ч. UTC

Пазарно говорене

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23.03.2026 г., 21:10 ч. UTC

Значими събития в новините

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Значими събития в новините

Basic Materials Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Walker & Dunlop Inc Прогноза

Ценова цел

By TipRanks

48.33% нагоре

12-месечна прогноза

Среден 65 USD 48.33%

Висок 65 USD

Нисък 65 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Walker & Dunlop Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Walker & Dunlop Inc през последните 3 месеца.

Техническа оценка

By Trading Central

70.995 / 76.69Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Настроение

By Acuity

160 / 441 Класиране в Финансови

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.